NCT05469789View on ClinicalTrials.gov

A Study of Lanadelumab in Teenagers and Adults With Hereditary Angioedema (HAE)

Active, not recruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

June 29, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Hereditary Angioedema (HAE)
Interventions
OTHER

No Intervention

As it is an observational study, no intervention is administered in this study.

Trial Locations (1)

E1 1BB

Barts Health NHS Trust, London

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY